Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04555161 · ClinicalTrials.gov registry record · NA
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
A NA study of Pulmonary Hypertension and Pulmonary Arterial Hypertension, sponsored by Aria CV.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 12
- Study locations
NCT04555161 is a NA study of Pulmonary Hypertension and Pulmonary Arterial Hypertension that is actively recruiting participants, run by Aria CV. The registered enrollment target is 30 participants, below the 613-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (95% lower). The trial reports 12 study locations across 8 states.
The verdict
NCT04555161, a NA study of Pulmonary Hypertension and Pulmonary Arterial Hypertension, is actively recruiting participants, sponsored by Aria CV.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 12
- Study locations
Study Summary
This prospective study is a multi-center early feasibility study assessing the safety and performance of the Aria CV Pulmonary Hypertension System in patients with pulmonary hypertension and right heart dysfunction.
Conditions Studied
Interventions
- DEVICE Aria CV Pulmonary Hypertension System
Study Locations (12)
California
- University of California - San Diego - La Jolla
- University of California-Los Angeles - Los Angeles
Minnesota
- University of Minnesota - Minneapolis
- Mayo Clinic - Rochester
New York
- Cornell University - New York
- University of Rochester - New York
Ohio
- The Christ Hospital - Cincinnati
- Ohio Health - Columbus
Indiana
- St. Vincent Health - Indianapolis
Massachusetts
- Brigham and Women's Hospital - Boston
South Carolina
- Medical University of South Carolina - Charleston
Wisconsin
- Aurora St Luke's Medical Center - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-03-15 |
| Est. Completion | 2026-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04555161
The ClinicalTrials.gov registry entry for NCT04555161 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 613-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (95% lower). The listed sponsor is Aria CV, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Pulmonary Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Aria CV Pulmonary Hypertension System is the first listed.
NCT04555161 reports 12 study locations spanning 8 distinct geographic areas - top geographies include California, Minnesota, New York.
Frequently Asked Questions
What is clinical trial NCT04555161 about?
NCT04555161 is a clinical study titled "Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System". This prospective study is a multi-center early feasibility study assessing the safety and performance of the Aria CV Pulmonary Hypertension System in patients with pulmonary hypertension and right heart dysfunction.
What is the current status of trial NCT04555161?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2021-03-15. Estimated completion is 2026-10.
What conditions does trial NCT04555161 study?
This clinical trial studies the following conditions: Pulmonary Hypertension, Pulmonary Arterial Hypertension, Right Heart Dysfunction.
What interventions are being tested in trial NCT04555161?
The interventions under investigation include: Aria CV Pulmonary Hypertension System (DEVICE).
Who is sponsoring clinical trial NCT04555161?
This trial is sponsored by Aria CV, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04555161 being conducted?
This trial has 12 study locations across California, Indiana, Massachusetts, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
RECRUITING · NA
-
Evaluating Infrasonic Hemodynography
RECRUITING · NA
-
Identifying Right Ventricular Dysfunction in COPD Through Right Heart Catheterization, Imaging and Exercise
RECRUITING · NA
-
iTONE Trial (exercIse Training in pulmONary hypertEnsion) Exercise Program for Pediatric PH
RECRUITING · NA
-
Feto-Endoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic Hernia
RECRUITING · NA
-
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.